Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas Durek

Showing results (31-40 of 89) with videos related to

Pageof 9
Sort By:
FEMS Yeast Research|December 18, 2025
Yeast as a tool for exploring disulfide-rich peptidesKuok Yap, Owen T Porth, Jing Xie, et al.
Journal of the American Chemical Society|November 11, 2021
Enzymatic C-Terminal Protein Engineering with AminesFabian B H Rehm, Tristan J Tyler, Kuok Yap, et al.
Biochemistry|February 18, 2026
Rational Design of Plant-Derived Protein Ligases with Altered Substrate SpecificityYan Zhou, Simon J de Veer, Tristan J Tyler, et al.
Bioconjugate Chemistry|June 1, 2017
Europium-Labeled Synthetic C3a Protein as a Novel Fluorescent Probe for Human Complement C3a ReceptorAline Dantas de Araujo, Chongyang Wu, Kai-Chen Wu, et al.
Science (New York, N.Y.)|October 25, 2003
Structure of Rab GDP-dissociation inhibitor in complex with prenylated YPT1 GTPaseAlexey Rak, Olena Pylypenko, Thomas Durek, et al.
Biochemical Pharmacology|March 14, 2012
Characterisation of Na(v) types endogenously expressed in human SH-SY5Y neuroblastoma cellsIrina Vetter, Christine A Mozar, Thomas Durek, et al.
Journal of the American Chemical Society|June 11, 2025
Asparaginyl Ligases with Engineered Substrate Specificity for Controlled, Sequential Transpeptidation ReactionsYan Zhou, Simon J de Veer, Tristan J Tyler, et al.
European Journal of Medicinal Chemistry|March 22, 2014
Disulfide-rich macrocyclic peptides as templates in drug designSusan E Northfield, Conan K Wang, Christina I Schroeder, et al.
The Journal of Organic Chemistry|June 12, 2014
Fmoc-based synthesis of disulfide-rich cyclic peptidesOlivier Cheneval, Christina I Schroeder, Thomas Durek, et al.
Journal of Medicinal Chemistry|November 16, 2022
Engineering the Cyclization Loop of MCoTI-II Generates Targeted Cyclotides that Potently Inhibit Factor XIIaSixin Tian, Thomas Durek, Conan K Wang, et al.
Pageof 9

Showing results (31-40 of 89) with videos related to

Sort By:
Pageof 9
FEMS Yeast Research|December 18, 2025
Yeast as a tool for exploring disulfide-rich peptidesKuok Yap, Owen T Porth, Jing Xie, et al.
Journal of the American Chemical Society|November 11, 2021
Enzymatic C-Terminal Protein Engineering with AminesFabian B H Rehm, Tristan J Tyler, Kuok Yap, et al.
Biochemistry|February 18, 2026
Rational Design of Plant-Derived Protein Ligases with Altered Substrate SpecificityYan Zhou, Simon J de Veer, Tristan J Tyler, et al.
Bioconjugate Chemistry|June 1, 2017
Europium-Labeled Synthetic C3a Protein as a Novel Fluorescent Probe for Human Complement C3a ReceptorAline Dantas de Araujo, Chongyang Wu, Kai-Chen Wu, et al.
Science (New York, N.Y.)|October 25, 2003
Structure of Rab GDP-dissociation inhibitor in complex with prenylated YPT1 GTPaseAlexey Rak, Olena Pylypenko, Thomas Durek, et al.
Biochemical Pharmacology|March 14, 2012
Characterisation of Na(v) types endogenously expressed in human SH-SY5Y neuroblastoma cellsIrina Vetter, Christine A Mozar, Thomas Durek, et al.
Journal of the American Chemical Society|June 11, 2025
Asparaginyl Ligases with Engineered Substrate Specificity for Controlled, Sequential Transpeptidation ReactionsYan Zhou, Simon J de Veer, Tristan J Tyler, et al.
European Journal of Medicinal Chemistry|March 22, 2014
Disulfide-rich macrocyclic peptides as templates in drug designSusan E Northfield, Conan K Wang, Christina I Schroeder, et al.
The Journal of Organic Chemistry|June 12, 2014
Fmoc-based synthesis of disulfide-rich cyclic peptidesOlivier Cheneval, Christina I Schroeder, Thomas Durek, et al.
Journal of Medicinal Chemistry|November 16, 2022
Engineering the Cyclization Loop of MCoTI-II Generates Targeted Cyclotides that Potently Inhibit Factor XIIaSixin Tian, Thomas Durek, Conan K Wang, et al.
Pageof 9